ABO血液型不適合移植の新戦略―2008―

出版社： 日本医学館
著者：
発行日： 2008-07-22
分野： 臨床医学：内科  >  腎臓
ISBN： 9784890446599
電子書籍版： 2008-07-22 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

5,500 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,750 円(税込)

購入する

商品紹介

本書の内容は、日本ABO血液型不適合移植研究会の第14回学術集会（2007年8月5日、於ヒルトン名古屋）での発表内容を中心にまとめられてものです。

目次

  • ABO血液型不適合移植の新戦略―2008―

    ―目次―

    第14回日本ABO血液型不適合移植研究会
    主題：ABO血液型不適合臓器移植における免疫抑制療法

    統計
    　1．わが国におけるABO血液型不適合腎移植の現況報告2007
    　1．ABO血液型不適合生体肝移植2007年集計報告

    REPORT
    　坑A坑B抗体値測定における施設間格差の検討（第5報）

    肝移植
    　1．肝類洞内皮細胞によるB細胞免疫寛容誘導の可能性
    　2．坑血液型抗体産生B細胞の分化様式に即した脾摘を含まない
    　　　免疫抑制法によるABO血液型不適合腎移植と肝移植の各1例
    　3．成人AOB血液型不適合生体肝移植における
    　　　シクロスポリン4時間静注法の導入

    腎移植
    　1．低用量坑CD20モノクローナル抗体(retuximab)を用いた
    　　　ABO血液型不適合腎移植の検討
    　2．リツキマシブを投与し脾摘を行わず施行した
    　　　夫婦間ABO血液型不適合腎移植の6例
    　3．脾摘を行わないABO血液型不適合腎移植
    　4．ABO血液型不適合腎移植における血液型抗体対策の簡略化
    　　　―術前低抗体値症例に対する脾摘回避・リツキシマブ
    　　　　非使用プロトコールの経験―

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第14回日本ABO血液型不適合移植研究会 主題 : ABO血液型不適合臓器移植における免疫抑制療法

P.15 掲載の参考文献
1) Takahashi K, Saito K, Tanabe K et al: Multicenter cooperative study group. First report of a seven-year survey on ABO-incompatible kidney transplantation in japan. Clin Exp Nephrol 5: 119-125, 2001.
 
2) Takahashi K, Saito K, Takahara S et al.: Excellent long-teRm outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4: 1089-1096, 2004.
PubMed
3) Takahashi K, Saito K, The Japanese ABO-incompatible Kidney Transplantation Committee: Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplant 13: 118-112, 2006.
 
4) Takahashi K: ABO-incompatible organ transplantation. Curr Opin Organ Transplant 12: 409-414, 2007.
 
5) Takahashi K: Chapter 6. Accommodation in ABO-incompatible kidney transplantation-Why do kidney grafts survive? Accommodation in ABO-incompatible Kidney Transplantation. Elsevier, Amsterdam, 2004, p37-52.
 
6) Takahashi K: A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 19 (Suppl 14) : 76-85, 2005.
 
7) Takahashi K: A new immunosuppressive therapy in ABO-incompatible kidney transplantation besed on a new concept of accommodation. ABO-incompatible organ transplantation from Japan. (ed. Takahashi K), Elsevier, Amsterdam, 2006, p73-87.
 
8) Ogawa H, Mohiuddin MM, Galili U et al.: Mouse-heart grafts expressing an incompatible carbohydrate antigen. II Transition from accommodation to tolerance. Transplantation 77 : 366-373, 2004.
PubMed
9) Galili U: Xenotransplantation and ABO-incompatible transplantation; the similarities they share. Transfus Apher Sci 35 : 45-58, 2006.
PubMed
10) West LJ: B-cell tolerance following ABO-incompatible infant heart transplantation. Transplantation 81: 301-307, 2006.
PubMed
11) Egawa H, Oike F, Buhler L et al.: Impact of age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 77: 403-411, 2004.
PubMed
12) Takahashi K: Chapter 8: Timing of the start of immunosuppressive therapy (duration of desensitization therapy). Accommodation in ABO-incompatible kidney transplantation. Elsevier, Amsterdam, p94-95, 2004.
 
13) Saito K, Nakagawa Y, Takahashi K et aL: Pinpoint targeted immunosuppression; Anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplant 13 : 111-117, 2006.
 
14) Takahashi K: Recent findings of ABO-incompatible kidney transplantation-classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-bloog group-related antigens during critical period preceding establishment of accommodation. Clin Exp Nephrol 11: 128-141, 2007.
 
15) Tyden G, Kumlien G, Genberg H et al.: ABO-incompatible kidney transplantation without splenectomy using antigen-specific immunoadsorption and rituximab. Am J Transplant 5: 145-148, 2005.
PubMed
16) Alexandre GPJ, Squifflet JP, Bruyere MDE et al.:Splenectomy as a prerequisite for human ABO-incompatible renal transplantation. Transplant Proc 17: 138-143, 1985.
 
17) Takahashi K: A review of humoral rejection in ABO-incompatible kidney transpla-ntation with local (intrarenal) DIC as the underlying condition. Acta Med Biol 45: 95-102, 1997.
 
P.33 掲載の参考文献
1) Zhou W et al. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant. Transpl Immunol 12: 9-18, 2003.
PubMed
2) Ohdan H et al.: Evidence of immune tolerance to blood group antigens in a case of ABO-incompatible pediatric liver transplantation. Am J Transplant 7: 2190-2194, 2007.
 
3) Onoe T et al.: Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice. J Immunol 175: 139-146, 2005.
PubMed
4) Ohdan H et al.: Mac-1-negative B-lb phenotype of natural antibody-producing cells, including those responding to Gal alpha 1, 3 Gal epitopes in alpha 1, 3-galactosyltransferase-deficient mice. J Immunol 165: 5518-5529, 2000.
 
5) Ohdan H et al.: Mixed chimerism induced without lethal conditioning prevents T ce11-and anti-Gal alpha 1, 3Gal-mediated graft rejection. J Clin Invest 104: 281-290, 1999.
 
6) Clarkson MR et aL: T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 80 (5) : 555-563, 2005
PubMed
P.39 掲載の参考文献
1) Tanabe M, Shimazu M, Wakabayashi G et al.: Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73 (12) : 1959-1961, 2002.
PubMed
2) 齋藤和英, 高橋公太: わが国におけるABO血液型不適合腎移植の現況報告2006. ABO血液型不適合移植の新戦略2007. (高橋公太・田中紘一・編), 日本医学館, 東京, 2007, p24-37.
 
3) 江川裕人: ABO血液型不適合生体肝移植2006年集計報告. ABO血液型不適合移植の新戦略2007. (高橋公太・田中紘一・編), 日本医学館, 東京, 2007, p38-41.
 
4) 臼井正信, 櫻井洋至, 根本明喜・他: 術前抗CD20モノクローナル抗体 (リツキシマブ) 投与を含めたABO血液型不適合生体肝移植プロトコール. ABO血液型不適合移植の新戦略2006. (高橋公太・田中紘一・編), 日本医学館, 東京, 2006, p36-41.
 
5) 中川由紀, 斉藤和英, 諏訪道博・他: リツキシマブを用いたABO不適合腎移植. ABO血液型不適合移植の新戦略2006. (高橋公太・田中紘一・編), 日本医学館, 東京, 2006, p64-71.
 
6) Irei T, Ohdan H, Zhou W et al.: The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation. Blood 110 (13) : 4567-4575, 2007.
 
P.44 掲載の参考文献
1) McAlister VC, Haddad E, Renouf E et al.: Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 6: 1578-1585, 2006.
PubMed
2) Tanaka K, Lake J, Villamil F et al.: Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. Liver Transpl 11: 1395-1402, 2005.
PubMed
3) Levy G, Grazi GL, Sanjuan F et al.: 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Liver Transpl 12: 1464-1472, 2006.
PubMed
4) Berenguer M, Aguilera V, Prieto M et al.: Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients. Liver Transpl 12: 762-767, 2006.
PubMed
5) Tanabe M, Shimazu M, Wakabayashi G et al.: Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73: 1959-1961, 2002.
PubMed
6) Yoshizawa A, Sakamoto S, Ogawa K et aL: New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infunsion, and preservation of spleen. Transplant Proc 37: 1718-1719, 2005.
 
7) Usuda M, Fujimori K, Koyamada N et al.: Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation 79: 12-16, 2005.
PubMed
P.49 掲載の参考文献
1) Takahashi K, Saito K, Takahara S et al.: Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4: 1089-1096, 2004.
PubMed
2) Alexandre GP, Squiffletb JP, De Bruyere M et al.: Present experiences in series of 26 ABO-incompatible living donor renal allografts. Transplantation Proc 19: 4538, 1987.
 
3) Tydwn G, Kumlien G, Genberg H et al.: ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5 : 145-148, 2004.
 
4) Saito K, Nakagawa Y, Suwa M et al.: Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplantation 13 : 111-117, 2006.
PubMed
5) Ishida H, Miyamoto N, Shirakawa H et al.: Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transplant 7 : 825-831, 2007.
PubMed
6) Schroder C, Azimzadeh AM, Wu G et al.: Anti-CD20 treatment depletes B-cell in blood and lymphatic tissue of cynomolgus monkeys. Transpl Immunol 12: 19-28, 2003.
 
7) Sidner RA, Book BK, Agarwal A et al.: In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody. Hum Antibodies 13 : 55-62, 2004.
 
8) Genberg H, Hansson A, Wernerson A et al.: Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant 6: 2418-2428, 2007.
 
9) Suzan F, Ammor M, Ribrag V: Fatal reactivation of cytomegalovirus infection after use of rituximab for posttransplantation lymphoproliferative disorder. N Engl J Med 345 : 1000, 2001.
 
10) CM Bearden, A Agarwal, BK Book et al.: Rituximab inhibited the in vivo primary and secondary antibody response to a neoantigen, bacteruophage phil74. Am J Transplant 5 : 50-57, 2005.
 
P.55 掲載の参考文献
1) 河村毅, 荻原秀隆, 相川厚, 新井兼司, 小原武博, 長谷川昭:ABO式血液型不適合腎移植-夫婦間, 第2次, 3次移植の臨床成績. 泌尿器外科 18(4) : 315-323, 2005.
Medical*Online
2) 高橋公太: わが国のABO不適合腎移植の検討-第10回アンケート調査報告-. 今日の移植 19(6) : 626-637, 2006.
 
3) Teraaski Pl, Cecka JM, Gjertson DW et al.: High survival rate of kidney transplantation from pousal and living umelated donors. N Eng J Med 333 (6) : 333-336, 1995.
 
4) 相川厚: 血液型不適合腎移植-Accomodationと臨床成績-. 東邦医学会雑誌 54(6) : 323-330, 2007.
 
5) Mun Woo Y, Gill JS, Johnson N et al.: The advanced age decrease kidney donor: current outcomes and future opportunities. Kidney Int 67 : 2407-2414, 2005.
 
P.62 掲載の参考文献
1) Alexandre GPJ et al.: Splenectomy as a prerequeste for successful human ABO-incompatible renal transplantation. Transplant Proc 17: 138-143, 1985.
 
2) Takahashi K: Accommodation in ABO-incompatible kidney transplantation: why do kidney graft survive? Transplant Proc 36 (S2S) : 193S-196S, 2004.
 
3) Tyden G et al.: Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 76 (4) : 730-734, 2003.
PubMed
4) Saito K et al.: Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO incompatible kidney transplantation without splenectomy. Xenotransplantation 13: 111-117, 2006.
PubMed
5) Irei T et al.: The persistent elimination of B cells responding blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept of preventing antibody-mediated rejection in ABO-incompatible transplantation. Blood 110: 4567-4575, 2007.
 
6) Sonnenday CJ et al.: Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transpl 4: 1315-1322, 2004.
 
P.68 掲載の参考文献
1) Katayama A, Kobayashi T, Uchida K, Goto N, Matsuoka S et al.: Beneficial effect of antibody removal and enhanced immuno supPression in flow cytometry cross match-positive and ABO incompatible renal transplantation. Transplantation Proceedings 34 : 2771-2772, 2002.
PubMed
2) 片山昭男, 打田和治, 後藤憲彦, 松岡慎, 佐藤哲彦・他: シクロフォスファミドを導入療法に用いたABO血液型不適合腎移植免疫抑制療法. ABO血液型不適合移植の新戦略2002. (高橋公太・田中紘一・編), 日本医学館, 東京, 2002, p22-27.
 
3) ABO血液型不適合生体腎移植の免疫抑制療法- Basiliximab induction, カルシニューリンインヒビターAUCモニタリングによるクリニカルパス導入症例を中心に-. ABO血液型不適合移植の新戦略2007. (高橋公太・田中紘一・編), 日本医学館, 東京, 2007, p81-86.
 

書評

最近チェックした商品履歴

Loading...